QA: Regulus Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2019_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 19,295,000
1 IntangibleAssetsNetIncludingGoodwill 500,000
2 PropertyPlantAndEquipmentNet 7,806,000
3 remainder_Assets 326,000
4 LiabilitiesCurrent 26,646,000
5 LiabilitiesNoncurrent 315,000
6 remainder_Liabilities 6,820,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,686,409
9 ResearchAndDevelopmentExpense -1,452,420
10 remainder_Expenses 2,323,180
11 remainder_Revenues 620,034
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -4,653
  yvar yval
0 Assets 27,927,000
1 Liabilities 33,781,000
2 Expenses 9,557,169
3 Revenues 620,034
4 StockholdersEquity -5,854,000
5 NetIncome -8,937,135
6 ComprehensiveNetIncome -8,939,462
7 BaseVar 35,944,928
8 EconomicCapitalRatiobeforeLimitedLiability -0.703
9 EconomicCapitalRatio 1.36

Edgar->Model Mapping

Feature Distribution

Change over Time